{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:38:58Z","timestamp":1792251538757,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.bbagen.2009.02.013","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T04:22:30Z","timestamp":1236054150000},"page":"566-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Amyloid inhibitors enhance survival of cultured human islets"],"prefix":"10.1016","volume":"1790","author":[{"given":"Kathryn J.","family":"Potter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A.","family":"Scrocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth L.","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziliang","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika A.","family":"Younker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lipsett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bruce","family":"Verchere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2009.02.013_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00125-003-1304-4","article-title":"Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes?","volume":"47","author":"Clark","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2009.02.013_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343","author":"Hoppener","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2009.02.013_bib4","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbagen.2009.02.013_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diabetes.48.2.241","article-title":"Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes","volume":"48","author":"Kahn","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2009.02.013_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0531-5565(03)00004-4","article-title":"Islet amyloid polypeptide and type 2 diabetes","volume":"38","author":"Marzban","year":"2003","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.bbagen.2009.02.013_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/BF02743276","article-title":"Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway","volume":"36","author":"Kahn","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2009.02.013_bib8","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1210\/me.2004-0407","article-title":"Processing of pro-islet amyloid polypeptide in the constitutive and regulated secretory pathways of beta cells","volume":"19","author":"Marzban","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bbagen.2009.02.013_bib9","first-page":"609","article-title":"Human islet amyloid polypeptide expression in COS 1 cells. A model of intracellular amyloidogenesis","volume":"147","author":"O'Brien","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib10","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/diabetes.54.7.2117","article-title":"Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation","volume":"54","author":"Paulsson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2009.02.013_bib11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2337\/diab.38.11.1333","article-title":"Hyperproinsulinemia and amyloid in NIDDM: clues to etiology of islet \u03b2-cell dysfunction?","volume":"38","author":"Porte","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2009.02.013_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF00290389","article-title":"Non-uniform distribution of islet amyloid in the pancreas of \u2018maturity-onset\u2019 diabetic patients","volume":"27","author":"Clark","year":"1984","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2009.02.013_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2337\/diab.40.3.305","article-title":"Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes?","volume":"40","author":"Steiner","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2009.02.013_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03009737509178999","article-title":"Amyloid of medullary carcinoma of the thyroid; partial characterization","volume":"80","author":"Westermark","year":"1975","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.bbagen.2009.02.013_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2009.02.013_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/diab.40.2.166","article-title":"\u03b2-cells in type II diabetes mellitus","volume":"40","author":"Porte","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2009.02.013_bib17","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1210\/jc.2005-0079","article-title":"Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3\u2032-kinase-dependent pathway","volume":"90","author":"Lin","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbagen.2009.02.013_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"Pancreatic islet cell toxicity of amylin associated with type 2 diabetes mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2009.02.013_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF00402271","article-title":"Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population","volume":"36","author":"de Koning","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2009.02.013_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s001250051175","article-title":"Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model","volume":"42","author":"Hoppener","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2009.02.013_bib21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2337\/diabetes.47.5.743","article-title":"Islet amyloid-associated diabetes in obese A(vy)\/a mice expressing human islet amyloid polypeptide","volume":"47","author":"Soeller","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2009.02.013_bib22","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","article-title":"Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide","volume":"93","author":"Verchere","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.02.013_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00400722","article-title":"Rapid deposition of amyloid in human islets transplanted into nude mice","volume":"38","author":"Westermark","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2009.02.013_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMc0802893","article-title":"Widespread amyloid deposition in transplanted human pancreatic islets","volume":"359","author":"Westermark","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2009.02.013_bib25","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02264","article-title":"Folding proteins in fatal ways","volume":"426","author":"Selkoe","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2009.02.013_bib26","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2337\/diabetes.54.7.2235","article-title":"Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide","volume":"54","author":"Hull","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2009.02.013_bib27","doi-asserted-by":"crossref","first-page":"C1586","DOI":"10.1152\/ajpcell.00208.2007","article-title":"Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro","volume":"293","author":"Hull","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-2836(02)00164-X","article-title":"Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis","volume":"318","author":"Scrocchi","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib29","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1021\/bi048582a","article-title":"Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions","volume":"43","author":"Porat","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2009.02.013_bib30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.chembiol.2005.05.010","article-title":"Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid-core-containing hexapeptide","volume":"12","author":"Tatarek-Nossol","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib31","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0507471103","article-title":"Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis","volume":"103","author":"Yan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.02.013_bib32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/jmbi.2001.4593","article-title":"Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis","volume":"308","author":"Jaikaran","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0022-2836(02)00887-2","article-title":"Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide","volume":"322","author":"Mazor","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1047-8477(02)00630-5","article-title":"Identification of minimal peptide sequences in the (8\u201320) domain of human islet amyloid polypeptide involved in fibrillogenesis","volume":"141","author":"Scrocchi","year":"2003","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib35","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.02.013_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2009.02.013_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nm1234","article-title":"Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo","volume":"11","author":"Klyubin","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2009.02.013_bib38","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2337\/diabetes.54.8.2287","article-title":"Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts","volume":"54","author":"Nyqvist","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2009.02.013_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00006676-200004000-00008","article-title":"Cell loss in isolated human islets occurs by apoptosis","volume":"20","author":"Paraskevas","year":"2000","journal-title":"Pancreas"},{"key":"10.1016\/j.bbagen.2009.02.013_bib40","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1073\/pnas.91.18.8467","article-title":"Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide","volume":"91","author":"de Koning","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.02.013_bib41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2009.02.013_bib42","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1073\/pnas.97.14.7999","article-title":"In vitro cultivation of human islets from expanded ductal tissue","volume":"97","author":"Bonner-Weir","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2009.02.013_bib43","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1210\/jc.2004-0761","article-title":"Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet beta-cells from pancreatic duct cells and an increase in functional beta-cell mass","volume":"90","author":"Suarez-Pinzon","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbagen.2009.02.013_bib44","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nbt1115","article-title":"New sources of pancreatic beta-cells","volume":"23","author":"Bonner-Weir","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib45","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ncb1104-1021","article-title":"Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine","volume":"6","author":"Halban","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib46","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/nbt1004","article-title":"Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages","volume":"22","author":"Seaberg","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2009.02.013_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2009.02.013_bib48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.1104345","article-title":"Type 2 diabetes\u2014a matter of beta-cell life and death?","volume":"307","author":"Rhodes","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2009.02.013_bib49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00401195","article-title":"Islet amyloid polypeptide\u2014a novel controversy in diabetes research","volume":"35","author":"Westermark","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2009.02.013_bib50","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s001250100601","article-title":"Islet amyloid polypeptide promotes beta-cell proliferation in neonatal rat pancreatic islets","volume":"44","author":"Karlsson","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2009.02.013_bib51","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.2337\/db08-0485","article-title":"Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture","volume":"57","author":"Marzban","year":"2008","journal-title":"Diabetes"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416509000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416509000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:41:53Z","timestamp":1759635713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416509000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0304416509000403"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2009.02.013","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloid inhibitors enhance survival of cultured human islets","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2009.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}